Blood-Based Test Could Help Identify Hard-to-Detect Gastrointestinal Cancers
A blood test that’s being developed to detect cancer at its earliest stages was roughly 90% effective at detecting gastrointestinal cancers, including... Read More
Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global Meeting
At ASCO GI, Leap Therapeutics announced that in a trial of DKN-01 in patients with advanced gastric cancer, elevated expression of DKK1... Read More